Key result
Coronary artery calcium scoring effectively stratifies long-term cardiovascular risk across ethnicities, age groups, and sexes, with a CAC of 0 serving as a reliable negative risk factor.
Why the study?
This review aimed to demystify coronary artery calcium as a clinical decision-guiding tool and clarify who might benefit from its use in clinical practice.
Does coronary artery calcium (CAC) scoring improve cardiovascular risk stratification and event prediction compared to traditional risk scores?
Does coronary artery calcium (CAC) scoring improve cardiovascular risk stratification and event prediction compared to traditional risk scores?
Answers are grounded in this paper and cite their sources.
CAC scoring provides consistent cardiovascular risk stratification and may offer value beyond current guidelines, including in select young patients and those with a family history.
Coronary artery calcium (CAC) is a highly specific marker for coronary atherosclerosis. The CAC Consortium, a multicenter, retrospective, real-world cohort study, was established to investigate the association between CAC and long-term, cause-specific mortality. This review summarizes findings from CAC Consortium studies published between 2016 and 2020, aiming to demystify CAC as a clinical decision-guiding tool and push the limits of who might benefit from CAC in clinical practice. CAC has been shown to effectively stratify cardiovascular risk across ethnicities irrespective of age, sex, and risk factor burden. In comparison to other widely used risk scores, CAC appears to be most consistent in its ability to add to cardiovascular disease (CVD) event prediction. Beyond risk stratification, CAC has been shown to identify high-risk patient subgroups. While currently recommended only for patients at borderline or intermediate risk by the American College of Cardiology/American Heart Association (10-year atherosclerotic CVD event risk, 5% to < 20%), CAC scoring may also provide value in select young patients aged 30-49 years and in low-risk patients with a family history. While new studies emphasize that patients with a CAC greater than or equal to 1000 be considered a distinct patient group, a CAC of 0 has additionally emerged to be a reliable negative risk factor, identifying patients at low risk of both CVD and non-CVD mortality.
No takes yet. Share an insight, caveat, or question.
Adelhoefer et al. (2020) conducted a review in Asymptomatic adults free of known cardiovascular disease (n=66,636). Coronary artery calcium (CAC) scoring vs. CAC of 0 or lower CAC scores was evaluated on Long-term cause-specific mortality (coronary heart disease, cardiovascular disease, and non-CVD mortality). Coronary artery calcium scoring effectively stratifies long-term cardiovascular risk across ethnicities, age groups, and sexes, with a CAC of 0 serving as a reliable negative risk factor.
Synapse has enriched 10 related papers. Consider them for comparative context: